英夫利昔单抗、硫唑嘌呤或联合疗法用于治疗克罗恩病。 - Suppr

Infliximab, azathioprine, or combination therapy for Crohn's disease.

作者信息

Ruffolo Cesare, Scarpa Marco, Bassi Nicolò

出版信息

N Engl J Med. 2010 Sep 9;363(11):1086-7; author reply 1087-8. doi: 10.1056/NEJMc1005805.

DOI:10.1056/NEJMc1005805

PMID:20848681

Abstract

摘要

相似文献

Infliximab, azathioprine, or combination therapy for Crohn's disease.

N Engl J Med. 2010 Sep 9;363(11):1086-7; author reply 1087-8. doi: 10.1056/NEJMc1005805.

Infliximab, azathioprine, or combination therapy for Crohn's disease.

N Engl J Med. 2010 Apr 15;362(15):1383-95. doi: 10.1056/NEJMoa0904492.

Infliximab, azathioprine, or combination therapy for Crohn's disease.

N Engl J Med. 2010 Sep 9;363(11):1086; author reply 1087-8. doi: 10.1056/NEJMc1005805.

Infliximab, azathioprine, or combination therapy for Crohn's disease.

N Engl J Med. 2010 Sep 9;363(11):1086; author reply 1087-8. doi: 10.1056/NEJMc1005805.

Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: a cost-effectiveness analysis.

J Crohns Colitis. 2013 Mar;7(2):167-74. doi: 10.1016/j.crohns.2012.04.007. Epub 2012 May 22.

Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.

Gastroenterology. 2006 Oct;131(4):1362-3. doi: 10.1053/j.gastro.2006.08.054.

Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.

Inflamm Bowel Dis. 2005 Jun;11(6):618-20. doi: 10.1097/01.mib.0000164002.32735.c2.

Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.

Int J Infect Dis. 2013 Aug;17(8):e650-2. doi: 10.1016/j.ijid.2013.02.021. Epub 2013 Apr 15.

Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E54-5. doi: 10.1002/ibd.22998.

[Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].

Dtsch Med Wochenschr. 2013 Sep;138(38):1877. doi: 10.1055/s-0032-1329164. Epub 2013 Sep 10.

引用本文的文献

Predicting mucosal healing in Crohn's disease: development of a deep-learning model based on intestinal ultrasound images.

Insights Imaging. 2025 Jun 16;16(1):125. doi: 10.1186/s13244-025-02014-5.

Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China.

Front Med (Lausanne). 2025 May 12;12:1566828. doi: 10.3389/fmed.2025.1566828. eCollection 2025.

Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database.

Front Pharmacol. 2025 Jan 8;15:1507196. doi: 10.3389/fphar.2024.1507196. eCollection 2024.

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis.

Front Pharmacol. 2025 Jan 3;15:1481678. doi: 10.3389/fphar.2024.1481678. eCollection 2024.

Exploring the relationship between and in inflammatory bowel disease (IBD): Insights and implications.

Comput Struct Biotechnol J. 2023 Nov 19;23:1-9. doi: 10.1016/j.csbj.2023.11.027. eCollection 2024 Dec.

Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United States.

BMC Gastroenterol. 2023 Mar 9;23(1):63. doi: 10.1186/s12876-023-02675-w.

In vitro models of intestinal epithelium: Toward bioengineered systems.

J Tissue Eng. 2021 Feb 1;12:2041731420985202. doi: 10.1177/2041731420985202. eCollection 2021 Jan-Dec.

Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.

Dig Dis Sci. 2022 Mar;67(3):997-1006. doi: 10.1007/s10620-021-06917-3. Epub 2021 Apr 5.

Association of polymorphisms in , , and with post-induction infliximab trough level in Crohn's disease patients.

Gastroenterol Rep (Oxf). 2019 Oct 29;8(5):367-373. doi: 10.1093/gastro/goz056. eCollection 2020 Oct.

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies.

Front Immunol. 2020 Aug 18;11:1951. doi: 10.3389/fimmu.2020.01951. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Infliximab, azathioprine, or combination therapy for Crohn's disease.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献